Harnessing acoustic speech parameters to decipher amyloid status in individuals with mild cognitive impairment

Alzheimer's disease (AD) is a neurodegenerative condition characterized by a gradual decline in cognitive functions. Currently, there are no effective treatments for AD, underscoring the importance of identifying individuals in the preclinical stages of mild cognitive impairment (MCI) to enable earl...

Description complète

Détails bibliographiques

Auteurs principaux:	Fernando García-Gutiérrez, Marta Marquié, Nathalia Muñoz, Montserrat Alegret, Amanda Cano, Itziar de Rojas, Pablo García-González, Clàudia Olivé, Raquel Puerta, Adelina Orellana, Laura Montrreal, Vanesa Pytel, Mario Ricciardi, Carla Zaldua, Peru Gabirondo, Wolfram Hinzen, Núria Lleonart, Ainhoa García-Sánchez, Lluís Tárraga, Agustín Ruiz, Mercè Boada, Sergi Valero
Format:	Artigo
Langue:	Inglês
Publié:	Frontiers Media S.A. 2023-09-01
Collection:	Frontiers in Neuroscience
Sujets:	Alzheimer's disease mild cognitive impairment early diagnosis cerebrospinal fluid biomarkers machine learning
Accès en ligne:	https://www.frontiersin.org/articles/10.3389/fnins.2023.1221401/full
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!